Treatment of chronic constipation by a bulk-forming laxative (Fibrolax).
Seventy-five patients affected by chronic constipation were treated for 4 weeks with an Ispaghula Husk preparation (Fibrolax), a bulk-forming laxative. Frequency, stool consistency, abdominal pain and signs of venous stasis improved after treatment. No important side-effect was recorded. Cholesterol, HDL-cholesterol and triglycerides did not show significant changes.
D000328:Adult; D000368:Aged; D002400:Cathartics / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D002400:Cathartics; D010936:Plant Extracts; D014280:Triglycerides; C037582:fibrolax; D002784:Cholesterol